 |
 |
Declan Fox wrote: > I quote this fascinating bit of neuro-transmitter research from some > French journal, abstract on PubMed. It struck me because our health > board prescribing advisers have tried to sink escitalopram, even going > so far as the pre-emptive strike of directing us to prescribe it > generically even though there won't be a generic along for a few years. Prescribing it by drug name (and by isomer) seems a good idea, regardless of the brands available. The advisers are drug reps, really, but regulated less effectively. Most of their output is spam. -- A